Sign In
Buy SANA
$3.13
-0.120 (-3.69%)
At Close: Jul 31, 2026
Sana Biotechnology to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
04:05pm, Tuesday, 07'th Sep 2021
SEATTLE, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today announced that it will webcast i
Week 34 MDA Breakout Stocks - August 2021: Short-Term Picks To Give You An Edge
03:21am, Monday, 23'rd Aug 2021
Two new Breakout Stocks for Week 34 with better than 10% short-term upside potential. The ETF/ETN forecast section now goes out in a separate article. Following the Momentum Gauges® the portfolio is
Sana Biotechnology Enters Long-Term Lease to Establish Manufacturing Facility to Enable Its Gene and Cell Therapy Product Candidates
04:10pm, Wednesday, 14'th Jul 2021
Facility to Support Allogeneic CAR T, Gene Therapy, and Stem Cell-Derived Therapies
Sana Biotechnology: Hypoimmune Cell Therapies
10:09pm, Wednesday, 30'th Jun 2021
Sana is the category leader for hypoimmune cell therapies that has the potential to transform diseases from oncology to CNS disorders and liver disease. Early data is promising, showing Sana's ability
First demonstration of the survival of allogeneic iPSCs transplanted into an immunocompetent non-human primate model without the need for immune suppression
Sana Biotechnology to Present During Plenary Sessions at ISSCR 2021 Virtual Annual Meeting
09:15am, Monday, 14'th Jun 2021
SEATTLE , June 14, 2021 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today announced that data will be prese
Sana Biotechnology to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
04:05pm, Wednesday, 02'nd Jun 2021
SEATTLE, June 02, 2021 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today announced that it will webcast it
Sana Biotechnology Reports First Quarter 2021 Financial Results and Business Updates
04:05pm, Wednesday, 05'th May 2021
Presented key proof of concept data for multiple platforms at AACR 2021
Sana Biotechnology to Present Pre-Clinical Data at American Society of Gene & Cell Therapy Annual Meeting 2021
04:35pm, Tuesday, 27'th Apr 2021
— Fusogen platform demonstrates potential for cell-specific in vivo delivery of gene therapies to multiple cell types, including T cells and hepatocytes —
Sana Biotechnology Reports Fourth Quarter and 2020 Financial Results and Business Updates
04:10pm, Wednesday, 24'th Mar 2021
Expects to present data at multiple scientific conferences in 2021
Regenerative Medicine Attracted Record $20 Billion in Funding in 2020
02:15pm, Tuesday, 23'rd Mar 2021
Cell and gene therapy companies are quickly emerging as favorites of venture capital firms, investors and members of Big Pharma, according to a report from the Alliance for Regenerative Medicine.
FUJIFILM Cellular Dynamics and Sana Biotechnology Announce License Agreement for the Development of iPSC-Derived Cell Therapies
09:00am, Wednesday, 17'th Mar 2021
MADISON, Wis. and SEATTLE, March 17, 2021 (GLOBE NEWSWIRE) -- FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem cells (iPSC) technologies,
Sana Biotechnology: An Ultra-Risky Bet
08:49pm, Monday, 08'th Feb 2021
A bet on Sana is essentially a bet on management given that all the company's drugs are in the preclinical stage. As the example of Juno shows, though the company may be a winning proposition in the n
Sana Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
05:24pm, Monday, 08'th Feb 2021
SEATTLE, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA), a company focused on creating and delivering engineered cells as medicines, today announced the closing of its upsiz
U.S. IPO Weekly Recap: Biotechs Flood The IPO Market In A 14 IPO Week
02:14am, Monday, 08'th Feb 2021
The IPO market had its busiest week yet this year with 14 IPOs raising $3.9 billion and 27 SPACs raising $9.2 billion. German chemicals group Atotech downsized and priced below the range to raise $498
